Press Releases
3 hours ago
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
‘When senior clinicians speak with a shared voice, it matters’: RCP publishes summary of January 2026 Council meeting
Indeterminate
Royal College of Physicians
Owner: Royal College of Physicians (Non-profit)
3 hours ago
Angitia Biopharmaceuticals Announces $130 Million Series D Financing
Indeterminate
GlobeNewswire, Inc.
3 hours ago
Medsynaptic Named 'Best in KLAS' 2026 Winner for PACS (Global) – Asia Segment
Neutral
EIN Presswire
2 hours ago
PathMaker Neurosystems Board Director, John Donoghue, Ph.D., Awarded 2026 Queen Elizabeth Prize for Engineering
Indeterminate
GlobeNewswire, Inc.
Feb. 2, 2026
From NFL to the Clinic: Same-Day Custom Orthoses Expand Nationwide
Neutral
EIN Presswire
2 hours ago
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
Indeterminate
GlobeNewswire, Inc.
Feb. 2, 2026
4 Principles, Real Impact: How Hospitals Are Advancing Maternal Health
Neutral
American Hospital Association
2 hours ago
Polaryx Therapeutics Welcomes New Members of the Board of Directors
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
Indeterminate
GlobeNewswire, Inc.
Feb. 2, 2026
BioPhy Acquired by Intrinsic Clinical Systems
Neutral
EIN Presswire
2 hours ago
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
2 hours ago
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Indeterminate
GlobeNewswire, Inc.